nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ADRA2A—attention deficit hyperactivity disorder	0.341	0.426	CbGaD
Trazodone—SLC6A4—attention deficit hyperactivity disorder	0.26	0.325	CbGaD
Trazodone—HTR2A—attention deficit hyperactivity disorder	0.2	0.25	CbGaD
Trazodone—ORM1—saliva—attention deficit hyperactivity disorder	0.00602	0.125	CbGeAlD
Trazodone—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00523	0.109	CbGeAlD
Trazodone—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00278	0.0577	CbGeAlD
Trazodone—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00129	0.0268	CbGeAlD
Trazodone—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00122	0.0254	CbGeAlD
Trazodone—HTR2B—forebrain—attention deficit hyperactivity disorder	0.00121	0.0252	CbGeAlD
Trazodone—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00109	0.0226	CbGeAlD
Trazodone—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.00103	0.0213	CbGeAlD
Trazodone—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.001	0.0208	CbGeAlD
Trazodone—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000919	0.0191	CbGeAlD
Trazodone—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000852	0.0177	CbGeAlD
Trazodone—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000847	0.0176	CbGeAlD
Trazodone—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000808	0.0168	CbGeAlD
Trazodone—ORM1—nervous system—attention deficit hyperactivity disorder	0.00078	0.0162	CbGeAlD
Trazodone—HRH1—forebrain—attention deficit hyperactivity disorder	0.000775	0.0161	CbGeAlD
Trazodone—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000762	0.0158	CbGeAlD
Trazodone—ORM1—central nervous system—attention deficit hyperactivity disorder	0.000751	0.0156	CbGeAlD
Trazodone—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000718	0.0149	CbGeAlD
Trazodone—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000701	0.0146	CbGeAlD
Trazodone—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000675	0.014	CbGeAlD
Trazodone—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000664	0.0138	CbGeAlD
Trazodone—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000658	0.0137	CbGeAlD
Trazodone—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000648	0.0134	CbGeAlD
Trazodone—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.00064	0.0133	CbGeAlD
Trazodone—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000634	0.0132	CbGeAlD
Trazodone—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00059	0.0123	CbGeAlD
Trazodone—HTR1A—nervous system—attention deficit hyperactivity disorder	0.00059	0.0122	CbGeAlD
Trazodone—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000568	0.0118	CbGeAlD
Trazodone—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000555	0.0115	CbGeAlD
Trazodone—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000548	0.0114	CbGeAlD
Trazodone—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000544	0.0113	CbGeAlD
Trazodone—HTR2C—brain—attention deficit hyperactivity disorder	0.000536	0.0111	CbGeAlD
Trazodone—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000524	0.0109	CbGeAlD
Trazodone—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000512	0.0106	CbGeAlD
Trazodone—SLC6A4—brain—attention deficit hyperactivity disorder	0.000508	0.0105	CbGeAlD
Trazodone—HTR2B—brain—attention deficit hyperactivity disorder	0.000503	0.0104	CbGeAlD
Trazodone—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000503	0.0104	CbGeAlD
Trazodone—HTR1A—brain—attention deficit hyperactivity disorder	0.000451	0.00936	CbGeAlD
Trazodone—Ziprasidone—DRD5—attention deficit hyperactivity disorder	0.000429	0.0387	CrCbGaD
Trazodone—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000428	0.00888	CbGeAlD
Trazodone—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000424	0.00881	CbGeAlD
Trazodone—HRH1—nervous system—attention deficit hyperactivity disorder	0.000421	0.00874	CbGeAlD
Trazodone—ADRA1A—brain—attention deficit hyperactivity disorder	0.000416	0.00863	CbGeAlD
Trazodone—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000413	0.00859	CbGeAlD
Trazodone—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000405	0.00842	CbGeAlD
Trazodone—Ziprasidone—ADRA2C—attention deficit hyperactivity disorder	0.000405	0.0365	CrCbGaD
Trazodone—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000398	0.00827	CbGeAlD
Trazodone—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000389	0.00808	CbGeAlD
Trazodone—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000363	0.0327	CrCbGaD
Trazodone—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000359	0.00745	CbGeAlD
Trazodone—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000352	0.0073	CbGeAlD
Trazodone—Vilazodone—SLC6A4—attention deficit hyperactivity disorder	0.000348	0.0314	CrCbGaD
Trazodone—Vilazodone—DRD2—attention deficit hyperactivity disorder	0.000346	0.0312	CrCbGaD
Trazodone—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000338	0.00703	CbGeAlD
Trazodone—Aripiprazole—DRD5—attention deficit hyperactivity disorder	0.000335	0.0302	CrCbGaD
Trazodone—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000331	0.00687	CbGeAlD
Trazodone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000325	0.00676	CbGeAlD
Trazodone—HRH1—brain—attention deficit hyperactivity disorder	0.000322	0.00668	CbGeAlD
Trazodone—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00032	0.00665	CbGeAlD
Trazodone—Aripiprazole—ADRA2C—attention deficit hyperactivity disorder	0.000316	0.0285	CrCbGaD
Trazodone—ADRA2A—brain—attention deficit hyperactivity disorder	0.000316	0.00656	CbGeAlD
Trazodone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000313	0.00651	CbGeAlD
Trazodone—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000308	0.0064	CbGeAlD
Trazodone—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000301	0.00626	CbGeAlD
Trazodone—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00028	0.00582	CbGeAlD
Trazodone—HTR2A—brain—attention deficit hyperactivity disorder	0.000269	0.00558	CbGeAlD
Trazodone—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000248	0.0224	CrCbGaD
Trazodone—CYP2D6—brain—attention deficit hyperactivity disorder	0.000245	0.00508	CbGeAlD
Trazodone—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00023	0.00478	CbGeAlD
Trazodone—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000222	0.00461	CbGeAlD
Trazodone—Ziprasidone—DRD4—attention deficit hyperactivity disorder	0.000219	0.0198	CrCbGaD
Trazodone—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000217	0.0045	CbGeAlD
Trazodone—Loxapine—DRD5—attention deficit hyperactivity disorder	0.000215	0.0194	CrCbGaD
Trazodone—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.00021	0.0189	CrCbGaD
Trazodone—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.000202	0.0183	CrCbGaD
Trazodone—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.000198	0.0178	CrCbGaD
Trazodone—Ziprasidone—HTR1B—attention deficit hyperactivity disorder	0.000195	0.0176	CrCbGaD
Trazodone—Domperidone—DRD3—attention deficit hyperactivity disorder	0.000192	0.0173	CrCbGaD
Trazodone—Ziprasidone—DRD3—attention deficit hyperactivity disorder	0.000189	0.0171	CrCbGaD
Trazodone—Clozapine—HRH3—attention deficit hyperactivity disorder	0.000186	0.0168	CrCbGaD
Trazodone—Ziprasidone—DRD1—attention deficit hyperactivity disorder	0.000186	0.0167	CrCbGaD
Trazodone—ABCB1—brain—attention deficit hyperactivity disorder	0.000176	0.00366	CbGeAlD
Trazodone—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000175	0.0158	CrCbGaD
Trazodone—Ziprasidone—ADRA2A—attention deficit hyperactivity disorder	0.000173	0.0156	CrCbGaD
Trazodone—Aripiprazole—DRD4—attention deficit hyperactivity disorder	0.000171	0.0155	CrCbGaD
Trazodone—Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.00017	0.0153	CrCbGaD
Trazodone—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000157	0.0142	CrCbGaD
Trazodone—Aripiprazole—HTR1B—attention deficit hyperactivity disorder	0.000152	0.0137	CrCbGaD
Trazodone—Nefazodone—SLC6A3—attention deficit hyperactivity disorder	0.000148	0.0133	CrCbGaD
Trazodone—Aripiprazole—DRD3—attention deficit hyperactivity disorder	0.000148	0.0133	CrCbGaD
Trazodone—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.000146	0.0132	CrCbGaD
Trazodone—Aripiprazole—DRD1—attention deficit hyperactivity disorder	0.000145	0.0131	CrCbGaD
Trazodone—Nefazodone—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.0131	CrCbGaD
Trazodone—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000138	0.0124	CrCbGaD
Trazodone—Aripiprazole—ADRA2A—attention deficit hyperactivity disorder	0.000135	0.0122	CrCbGaD
Trazodone—Domperidone—DRD2—attention deficit hyperactivity disorder	0.000133	0.012	CrCbGaD
Trazodone—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000132	0.0119	CrCbGaD
Trazodone—Ziprasidone—SLC6A4—attention deficit hyperactivity disorder	0.000132	0.0119	CrCbGaD
Trazodone—Ziprasidone—DRD2—attention deficit hyperactivity disorder	0.000131	0.0118	CrCbGaD
Trazodone—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.000119	0.0107	CrCbGaD
Trazodone—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.000117	0.0105	CrCbGaD
Trazodone—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	0.000111	0.00998	CrCbGaD
Trazodone—Nefazodone—SLC6A4—attention deficit hyperactivity disorder	0.000111	0.00998	CrCbGaD
Trazodone—Loxapine—DRD4—attention deficit hyperactivity disorder	0.00011	0.0099	CrCbGaD
Trazodone—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000109	0.0098	CrCbGaD
Trazodone—Quetiapine—DRD4—attention deficit hyperactivity disorder	0.000107	0.00966	CrCbGaD
Trazodone—Aripiprazole—SLC6A4—attention deficit hyperactivity disorder	0.000103	0.00928	CrCbGaD
Trazodone—Aripiprazole—DRD2—attention deficit hyperactivity disorder	0.000102	0.00923	CrCbGaD
Trazodone—Ziprasidone—HTR2A—attention deficit hyperactivity disorder	0.000101	0.00913	CrCbGaD
Trazodone—Loxapine—HTR1B—attention deficit hyperactivity disorder	9.75e-05	0.00879	CrCbGaD
Trazodone—Thioproperazine—DRD2—attention deficit hyperactivity disorder	9.7e-05	0.00875	CrCbGaD
Trazodone—Quetiapine—HTR1B—attention deficit hyperactivity disorder	9.52e-05	0.00858	CrCbGaD
Trazodone—Loxapine—DRD3—attention deficit hyperactivity disorder	9.47e-05	0.00854	CrCbGaD
Trazodone—Loxapine—DRD1—attention deficit hyperactivity disorder	9.29e-05	0.00838	CrCbGaD
Trazodone—Perphenazine—DRD1—attention deficit hyperactivity disorder	9.25e-05	0.00834	CrCbGaD
Trazodone—Quetiapine—DRD3—attention deficit hyperactivity disorder	9.24e-05	0.00833	CrCbGaD
Trazodone—Clozapine—DRD4—attention deficit hyperactivity disorder	9.22e-05	0.00831	CrCbGaD
Trazodone—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	9.12e-05	0.00822	CrCbGaD
Trazodone—Quetiapine—DRD1—attention deficit hyperactivity disorder	9.07e-05	0.00818	CrCbGaD
Trazodone—Loxapine—SLC6A3—attention deficit hyperactivity disorder	8.81e-05	0.00794	CrCbGaD
Trazodone—Loxapine—ADRA2A—attention deficit hyperactivity disorder	8.64e-05	0.00779	CrCbGaD
Trazodone—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	8.6e-05	0.00775	CrCbGaD
Trazodone—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	8.55e-05	0.00771	CrCbGaD
Trazodone—Nefazodone—HTR2A—attention deficit hyperactivity disorder	8.51e-05	0.00767	CrCbGaD
Trazodone—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	8.43e-05	0.0076	CrCbGaD
Trazodone—Fluphenazine—DRD2—attention deficit hyperactivity disorder	8.25e-05	0.00744	CrCbGaD
Trazodone—Clozapine—HTR1B—attention deficit hyperactivity disorder	8.19e-05	0.00738	CrCbGaD
Trazodone—Clozapine—DRD3—attention deficit hyperactivity disorder	7.95e-05	0.00717	CrCbGaD
Trazodone—Aripiprazole—HTR2A—attention deficit hyperactivity disorder	7.91e-05	0.00713	CrCbGaD
Trazodone—Clozapine—DRD1—attention deficit hyperactivity disorder	7.8e-05	0.00704	CrCbGaD
Trazodone—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	7.5e-05	0.00676	CrCbGaD
Trazodone—Clozapine—ADRA2A—attention deficit hyperactivity disorder	7.25e-05	0.00654	CrCbGaD
Trazodone—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	6.59e-05	0.00595	CrCbGaD
Trazodone—Loxapine—SLC6A4—attention deficit hyperactivity disorder	6.59e-05	0.00594	CrCbGaD
Trazodone—Loxapine—DRD2—attention deficit hyperactivity disorder	6.55e-05	0.00591	CrCbGaD
Trazodone—Perphenazine—DRD2—attention deficit hyperactivity disorder	6.52e-05	0.00588	CrCbGaD
Trazodone—Quetiapine—DRD2—attention deficit hyperactivity disorder	6.4e-05	0.00577	CrCbGaD
Trazodone—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	6.37e-05	0.00575	CrCbGaD
Trazodone—Clozapine—DRD2—attention deficit hyperactivity disorder	5.5e-05	0.00496	CrCbGaD
Trazodone—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	5.1e-05	0.00459	CrCbGaD
Trazodone—Loxapine—HTR2A—attention deficit hyperactivity disorder	5.06e-05	0.00457	CrCbGaD
Trazodone—Perphenazine—HTR2A—attention deficit hyperactivity disorder	5.04e-05	0.00454	CrCbGaD
Trazodone—Quetiapine—HTR2A—attention deficit hyperactivity disorder	4.94e-05	0.00446	CrCbGaD
Trazodone—Clozapine—HTR2A—attention deficit hyperactivity disorder	4.25e-05	0.00383	CrCbGaD
Trazodone—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.19e-05	0.0003	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.18e-05	0.000299	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.16e-05	0.000298	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.06e-05	0.000291	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.06e-05	0.00029	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.04e-05	0.000289	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.04e-05	0.000289	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.02e-05	0.000288	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4e-05	0.000286	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.99e-05	0.000285	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.98e-05	0.000285	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.97e-05	0.000284	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.94e-05	0.000282	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.89e-05	0.000279	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.74e-05	0.000268	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.72e-05	0.000266	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.67e-05	0.000263	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.66e-05	0.000262	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.65e-05	0.000261	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.65e-05	0.000261	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.64e-05	0.00026	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.64e-05	0.00026	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.62e-05	0.000259	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.62e-05	0.000259	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.62e-05	0.000259	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.61e-05	0.000258	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.6e-05	0.000258	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.6e-05	0.000258	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.58e-05	0.000256	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.56e-05	0.000255	CbGpPWpGaD
Trazodone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.56e-05	0.000255	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.56e-05	0.000255	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.54e-05	0.000254	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.54e-05	0.000253	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.54e-05	0.000253	CbGpPWpGaD
Trazodone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.54e-05	0.000253	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.52e-05	0.000252	CbGpPWpGaD
Trazodone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.51e-05	0.000251	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.5e-05	0.00025	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.5e-05	0.00025	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.49e-05	0.00025	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.48e-05	0.000249	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.48e-05	0.000249	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.47e-05	0.000248	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.44e-05	0.000246	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.42e-05	0.000245	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.4e-05	0.000244	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.4e-05	0.000243	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.38e-05	0.000242	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.33e-05	0.000238	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.29e-05	0.000235	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.29e-05	0.000235	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.28e-05	0.000234	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.27e-05	0.000234	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.26e-05	0.000233	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.23e-05	0.000231	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.23e-05	0.000231	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.23e-05	0.000231	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.22e-05	0.00023	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.19e-05	0.000229	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.19e-05	0.000228	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.18e-05	0.000227	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.16e-05	0.000226	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.16e-05	0.000226	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.16e-05	0.000226	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.15e-05	0.000225	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.14e-05	0.000225	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.14e-05	0.000224	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.13e-05	0.000224	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.13e-05	0.000224	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.12e-05	0.000223	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.09e-05	0.000221	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.08e-05	0.00022	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.08e-05	0.00022	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.08e-05	0.00022	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.07e-05	0.00022	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.07e-05	0.00022	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.07e-05	0.000219	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.05e-05	0.000218	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.04e-05	0.000217	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.03e-05	0.000217	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.02e-05	0.000216	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.01e-05	0.000216	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.01e-05	0.000216	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.01e-05	0.000215	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	2.99e-05	0.000214	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.99e-05	0.000214	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.98e-05	0.000213	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.98e-05	0.000213	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.96e-05	0.000212	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.96e-05	0.000211	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	2.94e-05	0.000211	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.94e-05	0.00021	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.94e-05	0.00021	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.93e-05	0.00021	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.87e-05	0.000206	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.87e-05	0.000205	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.86e-05	0.000204	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.85e-05	0.000204	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.84e-05	0.000203	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.84e-05	0.000203	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.83e-05	0.000203	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.83e-05	0.000202	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.82e-05	0.000202	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.8e-05	0.0002	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.79e-05	0.0002	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.79e-05	0.000199	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.78e-05	0.000199	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.77e-05	0.000198	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.76e-05	0.000198	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.76e-05	0.000197	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.75e-05	0.000197	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.75e-05	0.000196	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.74e-05	0.000196	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.74e-05	0.000196	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.7e-05	0.000193	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.67e-05	0.000191	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.66e-05	0.00019	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.59e-05	0.000185	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.58e-05	0.000184	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.57e-05	0.000184	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.57e-05	0.000184	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.57e-05	0.000184	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.52e-05	0.00018	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.51e-05	0.00018	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.48e-05	0.000178	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.47e-05	0.000177	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.47e-05	0.000177	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.46e-05	0.000176	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.4e-05	0.000171	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.39e-05	0.000171	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.36e-05	0.000169	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	2.36e-05	0.000169	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.36e-05	0.000169	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.36e-05	0.000169	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.34e-05	0.000167	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.33e-05	0.000166	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	2.32e-05	0.000166	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.3e-05	0.000164	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.28e-05	0.000163	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.28e-05	0.000163	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.28e-05	0.000163	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.23e-05	0.000159	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.17e-05	0.000155	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	2.16e-05	0.000155	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.16e-05	0.000155	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.16e-05	0.000154	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.16e-05	0.000154	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.15e-05	0.000154	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.13e-05	0.000153	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.13e-05	0.000152	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	2.13e-05	0.000152	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.09e-05	0.000149	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.08e-05	0.000149	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.07e-05	0.000148	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.01e-05	0.000144	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2e-05	0.000143	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.98e-05	0.000142	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.98e-05	0.000141	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.94e-05	0.000139	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.94e-05	0.000139	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.94e-05	0.000139	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.93e-05	0.000138	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.91e-05	0.000137	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.9e-05	0.000136	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.89e-05	0.000135	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.89e-05	0.000135	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.88e-05	0.000134	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.87e-05	0.000133	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.86e-05	0.000133	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.83e-05	0.000131	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	1.81e-05	0.00013	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.8e-05	0.000129	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	1.8e-05	0.000129	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.8e-05	0.000129	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.76e-05	0.000126	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.76e-05	0.000126	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.75e-05	0.000125	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.73e-05	0.000124	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.73e-05	0.000124	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.73e-05	0.000124	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.7e-05	0.000121	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.7e-05	0.000121	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.68e-05	0.00012	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.68e-05	0.00012	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	0.000118	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	0.000118	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	0.000118	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.64e-05	0.000118	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.64e-05	0.000117	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.63e-05	0.000117	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.63e-05	0.000117	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.63e-05	0.000117	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.63e-05	0.000116	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.62e-05	0.000116	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.61e-05	0.000115	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.6e-05	0.000114	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.58e-05	0.000113	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.54e-05	0.00011	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.54e-05	0.00011	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.53e-05	0.000109	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.52e-05	0.000109	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.52e-05	0.000109	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.52e-05	0.000108	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.51e-05	0.000108	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.51e-05	0.000108	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.49e-05	0.000107	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.49e-05	0.000106	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.48e-05	0.000106	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.46e-05	0.000104	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.43e-05	0.000102	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.42e-05	0.000102	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.41e-05	0.000101	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.38e-05	9.88e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	1.31e-05	9.37e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.3e-05	9.33e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	1.3e-05	9.31e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.24e-05	8.88e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.23e-05	8.81e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.23e-05	8.79e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.22e-05	8.76e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.17e-05	8.37e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.06e-05	7.59e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.04e-05	7.45e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.01e-05	7.19e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.01e-05	7.19e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	9.89e-06	7.08e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	9.89e-06	7.07e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.82e-06	7.02e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.68e-06	6.92e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	9.32e-06	6.66e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.25e-06	6.62e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.19e-06	6.58e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.04e-06	5.75e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.04e-06	5.75e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	7.77e-06	5.56e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.65e-06	5.47e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.52e-06	4.67e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.49e-06	4.64e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	6.13e-06	4.39e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.09e-06	4.36e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.05e-06	4.33e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.63e-06	4.03e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.62e-06	4.02e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	5.62e-06	4.02e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.52e-06	3.95e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.13e-06	3.67e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.24e-06	3.03e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4e-06	2.86e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.61e-06	1.87e-05	CbGpPWpGaD
